Comparison of treatments, investigations and outcomes by study
| NMUH age ≥75 years (n=261) | NHF audit 2012–20133 (n=36 504) | EHFS II ≥80 years5 (n=3580) | |
|---|---|---|---|
| Diuretics (%) | 81.4 (loop only) | 91 (loop only) | 93 |
| ACEi/ARB (%) | 64.6 | 85 | 76 |
| β (%) Blocker | 49.3 | 82 | 53 |
| ARA (%) | 28.7 | 49 | 38 |
| Echo (%) | 23.5 (inpatient only) | 91 | 81 |
| Median LOS | 7 days | 8 days | – |
| Mortality (%) | Inpatient—13 | Inpatient—9.4 | Inpatient—10.7 |
| Median 337 days—30.7 | Median 222 days—15.6 | 12 month—28.4 |
ACEi, ACE inhibitor; ARA, aldosterone receptor antagonist; ARB, angiotensin receptor blocker; EHFS, European Heart Failure Survey; LOS, length of stay; NHF, National Heart Failure; NMUH, North Middlesex University Hospital.